查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627968

脑磁图市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Magnetoencephalography Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球脑磁图市场价值为2.235 亿美元，预计2024 年至2032 年将以11.1% 的复合年增长率强劲增长。性脑造影解决方案推动的。

癫痫、阿兹海默症和帕金森氏症等神经系统疾病的增加是加速市场成长的关键因素。这些病症需要先进的诊断工具来提高治疗效果。 MEG 具有卓越的时间分辨率，可提供即时大脑活动图谱，有助于识别异常的神经功能。它在诊断和规划癫痫等疾病的治疗方面的关键作用凸显了它在医学领域日益增长的重要性。

扩大研究应用进一步促进市场的上升轨迹。 MEG 的非侵入性功能是神经科学和认知研究不可或缺的一部分，可提供感觉处理和运动协调等大脑功能的详细见解。政府和私人实体对神经科学研究的资助不断增加，促进了脑磁图系统在全球的采用。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 2.235 亿美元
预测值 5.916 亿美元
复合年增长率 11.1%

市场依产品类型分为低温/传统系统和光泵磁力计 (OPM) 系统。低温系统领域预计将以9.4% 的复合年增长率成长，到2032 年将达到5 亿美元。而仍然被广泛使用。

MEG 的应用跨越临床和研究领域，到 2023 年，临床细分市场将占据 65% 的市场份额。随着研究工作发现 MEG 技术的新临床应用，该领域预计将会成长。

2023 年，北美市场占据主导地位，营收达 8,880 万美元。预计到 2032 年，该地区的复合年增长率将达到 10.5%，这得益于先进的医疗基础设施和对神经学研究的大量投资。随着脑相关疾病发生率的上升以及领先的神经科学研究机构的存在，北美仍然是全球 MEG 市场的重要贡献者。

总体而言，随着技术进步，对精准诊断的日益关注，使 MEG 市场在临床和研究应用领域持续成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 神经系统疾病盛行率不断上升
      • 脑磁图领域技术的快速进步
      • 在临床诊断和研究中的应用不断增长
    • 产业陷阱与挑战
      • 替代神经影像技术的可用性
      • 脑磁图系统成本高
  • 成长潜力分析
  • 技术景观
  • MEG 相对于 fMRI 和 EEG 的优势
  • 未来市场趋势
  • 管道分析
  • 全球 MEG 装置（按地区和国家）
    • 北美洲
      • 我们
      • 加拿大
    • 欧洲
      • 德国
      • 英国
      • 法国
    • 亚太地区
      • 中国
      • 日本
  • 品牌分析
  • 监管环境
  • 报销场景
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

  • 主要趋势
  • 低温系统/传统
  • OPM系统

第 6 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 临床
    • 癫痫
    • 自闭症
    • 失智
    • 中风
    • 创伤性脑损伤 (TBI)
    • 其他临床应用
  • 研究

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 影像中心
  • 学术及研究机构

第 8 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
  • 亚太地区
    • 中国
    • 日本
  • 世界其他地区 (RoW)

第 9 章：公司简介

  • Cerca Magnetics
  • Compumedics
  • CTF MEG
  • FieldLine
  • MEGIN
  • Ricoh USA
简介目录
Product Code: 5529

The Global Magnetoencephalography Market, valued at USD 223.5 million in 2023, is projected to grow at a robust CAGR of 11.1% from 2024 to 2032. This growth is driven by advancements in neuroscience and the increasing adoption of non-invasive brain imaging solutions for clinical and research purposes.

Rising neurological disorders such as epilepsy, Alzheimer's, and Parkinson's are key factors accelerating market growth. These conditions require advanced diagnostic tools to enhance treatment outcomes. MEG, with its exceptional temporal resolution, offers real-time brain activity mapping, aiding in identifying abnormal neural functions. Its critical role in diagnosing and planning treatments for conditions like epilepsy underscores its growing importance in the medical field.

Expanding research applications further contribute to the market's upward trajectory. MEG's non-invasive capabilities are integral to neuroscience and cognitive studies, providing detailed insights into brain functions such as sensory processing and motor coordination. Increasing funding from governmental and private entities for neuroscience research bolsters the adoption of MEG systems globally.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$223.5 Million
Forecast Value$591.6 Million
CAGR11.1%

The market is segmented by product type into cryogenic/conventional systems and optically pumped magnetometer (OPM) systems. The cryogenic systems segment is anticipated to grow at a CAGR of 9.4%, reaching USD 500 million by 2032. These systems, utilizing superconducting quantum interference devices (SQUIDs), remain widely used for their reliability and effectiveness in diagnosing neurological disorders.

Applications of MEG span clinical and research domains, with the clinical segment accounting for 65% market share in 2023. Its prominence in clinical settings is attributed to its efficacy in diagnosing and managing neurological and psychiatric conditions. The segment is expected to grow as research efforts uncover new clinical applications for MEG technology.

North America dominated the market in 2023, generating USD 88.8 million in revenue. The region's growth, forecasted at a CAGR of 10.5% through 2032, is supported by advanced healthcare infrastructure and substantial investments in neurological research. With rising incidences of brain-related disorders and the presence of leading neuroscience institutions, North America remains a significant contributor to the global MEG market.

Overall, the increasing focus on precision diagnostics, in line with technological advancements, positions the MEG market for sustained growth across clinical and research applications.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of neurological disorders
      • 3.2.1.2 Rapid technology advancements in the field of magnetoencephalography
      • 3.2.1.3 Growing applications in clinical diagnosis and research
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of alternative neuroimaging technologies
      • 3.2.2.2 High cost of magnetoencephalography systems
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Advantages of MEG over fMRI and EEG
  • 3.6 Future market trends
  • 3.7 Pipeline analysis
  • 3.8 Worldwide MEG installations, by region and country
    • 3.8.1 North America
      • 3.8.1.1 U.S.
      • 3.8.1.2 Canada
    • 3.8.2 Europe
      • 3.8.2.1 Germany
      • 3.8.2.2 UK
      • 3.8.2.3 France
    • 3.8.3 Asia Pacific
      • 3.8.3.1 China
      • 3.8.3.2 Japan
  • 3.9 Brand analysis
  • 3.10 Regulatory landscape
  • 3.11 Reimbursement scenario
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn and Units)

  • 5.1 Key trends
  • 5.2 Cryogenic systems/Conventional
  • 5.3 OPM systems

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Clinical
    • 6.2.1 Epilepsy
    • 6.2.2 Autism
    • 6.2.3 Dementia
    • 6.2.4 Stroke
    • 6.2.5 Traumatic brain injury (TBI)
    • 6.2.6 Other clinical applications
  • 6.3 Research

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Imaging centers
  • 7.4 Academic and research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
  • 8.5 Rest of the World (RoW)

Chapter 9 Company Profiles

  • 9.1 Cerca Magnetics
  • 9.2 Compumedics
  • 9.3 CTF MEG
  • 9.4 FieldLine
  • 9.5 MEGIN
  • 9.6 Ricoh USA